I‐Ju Yeh
Biochemistry, Genetics and Molecular Biology · Indiana University
Epigenetics and DNA MethylationHippo pathway signaling and YAP/TAZCancer-related gene regulationClick Chemistry and ApplicationsCancer therapeutics and mechanisms
Publications
24
Citations
392
Est. group size
—
Recurring co-author estimate
Active years
25
Publishing since 2002
Publication cadence
Publications per year over the last 10 years — averaging 2.0/year recently
Recent publications
- Spatial Changes in Hippocampal Transcriptomic Profiles Following Limbic Non-convulsive Status Epilepticus: Insights into Long-Term Inflammation and Cognitive Deficits
Molecular Neurobiology · 2026
- <scp>cGAS</scp> / <scp>STING</scp> ‐Independent Induction of Type I Interferon by Inhibitors of the Histone Methylase <scp>KDM5B</scp>
The FASEB Journal · 2025
- Editorial: Exploring small molecule probes: advancements and applications in pharmacological research
Frontiers in Pharmacology · 2025
- Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition
Frontiers in Oncology · 2022
- Inhibition of the histone demethylase, KDM5B, directly induces re-expression of tumor suppressor protein HEXIM1 in cancer cells
Breast Cancer Research · 2019
- Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer
Scientific Reports · 2019
- Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism
Cancer Letters · 2016
Publishes in
- The FASEB Journal×3
- ACS Chemical Biology×2
- Frontiers in Oncology×2
- Breast Cancer Research×1
- Scientific Reports×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile